deltatrials
Completed PHASE3 NCT00126399

A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea

Sponsor: CollaGenex Pharmaceuticals

Conditions Rosacea
Interventions doxycycline
Updated 5 times since 2017 Last updated: Aug 18, 2005 Started: Jun 30, 2004 Completion: Apr 30, 2005

This PHASE3 trial investigates Rosacea and is currently completed. CollaGenex Pharmaceuticals leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Jun 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • CollaGenex Pharmaceuticals
Data source: CollaGenex Pharmaceuticals

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.